Indications and uses
Temporary relief of pain associated with: Joint and Muscle Inflammation Nerve damage Fitness and Sports Injuries
Temporary relief of pain associated with: Joint and Muscle Inflammation Nerve damage Fitness and Sports Injuries
Adults: Take one capsule 2-3 times daily with or without food. Children: Ask a doctor before use if under 18 years of age.
Bottle contains tamper-evident seal under cap. Store at 20-25°C (68-77°F)
Drug Facts
| Active Ingredients (in each capsule): | Purpose |
|---|---|
| "HPUS" is an abbreviation for Homeopathic Pharmacopoeia of the United States | |
| Alpha-lipoic ac 1x HPUS (alpha-lipoic acid) | Antioxidant |
| Curcuma longa 1x (Turmeric extract) | Anti-inflammatory |
| Ocimum sanc 1x HPUS (Holy basil extract) | Anti-inflammatory |
| Olibanum 1x HPUS (Boswellia extract) | Anti-inflammatory |
| Rosmarinus 1x HPUS (Rosemary extract) | Analgesic |
| Salix Alba 1x HPUS (White willow extract) | Anti-inflammatory |
| Zingiber 1x HPUS (Ginger extract) | Anti-inflammatory |
Temporary relief of pain associated with:
Adults: Take one capsule 2-3 times daily with or without food. Children: Ask a doctor before use if under 18 years of age.
Bottle contains tamper-evident seal under cap. Store at 20-25°C (68-77°F)
Vegetarian capsule (hypromellose, water)
877-NOXICARE
Manufactured in USA for Truceuticals® Inc.
5530 Wisconsin Avenue, Suite 1550
Chevy Chase, MD 20815
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 51230-824-60 | 2019-11-27 | C162847 | 48780-1 | 9855d018-ea1d-cd31-e053-dbdaa90ab51a | NOXICARE™ Natural Pain Relief |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51230-824-60 | NOXICARE Natural Pain Relief | 60 in 1 BOTTLE | CAPSULE | 60 | 1 | |
| 51230-824-60 | NOXICARE Natural Pain Relief | 1 in 1 CARTON | CAPSULE | 1 | 1 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51230-824 | NOXICARE NATURAL PAIN RELIEF (.ALPHA.-LIPOIC ACID, TURMERIC, OCIMUM TENUIFLORUM TOP, INDIAN FRANKINCENSE, ROSEMARY, SALIX ALBA BARK, AND GINGER) CAPSULE [TRUCEUTICALS, LLC] | 1 | Legacy NDC, 2 package rows | 20130208_313a8be3-37f7-4e4f-aa24-04e031e4bb79.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| .Alpha.-Lipoic Acid | ACTIVE INGREDIENT | 73Y7P0K73Y | 1 | |
| Ginger | ACTIVE INGREDIENT | C5529G5JPQ | 1 | |
| Indian Frankincense | ACTIVE INGREDIENT | 4PW41QCO2M | 1 | |
| Ocimum Tenuiflorum Top | ACTIVE INGREDIENT | 34T63W8ULS | 1 | |
| Rosemary | ACTIVE INGREDIENT | IJ67X351P9 | 1 | |
| Salix Alba Bark | ACTIVE INGREDIENT | 205MXS71H7 | 1 | |
| Turmeric | ACTIVE INGREDIENT | 856YO1Z64F | 1 | |
| .Alpha.-Lipoic Acid | ACTIVE MOIETY | 73Y7P0K73Y | 1 | |
| Ginger | ACTIVE MOIETY | C5529G5JPQ | 1 | |
| Indian Frankincense | ACTIVE MOIETY | 4PW41QCO2M | 1 | |
| Ocimum Tenuiflorum Top | ACTIVE MOIETY | 34T63W8ULS | 1 | |
| Rosemary | ACTIVE MOIETY | IJ67X351P9 | 1 | |
| Salix Alba Bark | ACTIVE MOIETY | 205MXS71H7 | 1 | |
| Turmeric | ACTIVE MOIETY | 856YO1Z64F | 1 | |
| Hypromelloses | INACTIVE INGREDIENT | 3NXW29V3WO | 1 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 51230-824 | 51230-824-60 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| .Alpha.-Lipoic Acid | 73Y7P0K73Y | ACTIB |
| Turmeric | 856YO1Z64F | ACTIB |
| Ocimum Tenuiflorum Top | 34T63W8ULS | ACTIB |
| Indian Frankincense | 4PW41QCO2M | ACTIB |
| Rosemary | IJ67X351P9 | ACTIB |
| Salix Alba Bark | 205MXS71H7 | ACTIB |
| Ginger | C5529G5JPQ | ACTIB |
| Hypromelloses | 3NXW29V3WO | IACT |
| Water | 059QF0KO0R | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Hypromelloses | HYPROMELLOSE | 3NXW29V3WO | TABLET, ORALLY DISINTEGRATING / ORAL | 41 mg | ||
| Hypromelloses | HYPROMELLOSE | 3NXW29V3WO | TABLET, FILM COATED / ORAL | 582 mg | ||
| Hypromelloses | HYPROMELLOSE | 3NXW29V3WO | INSERT / VAGINAL | 54.21 mg | ||
| Hypromelloses | HYPROMELLOSE | 3NXW29V3WO | SUSPENSION / OPHTHALMIC | 0.5 %w/w | ||
| Hypromelloses | HYPROMELLOSE | 3NXW29V3WO | TABLET, EXTENDED RELEASE / ORAL | 1472 mg | ||
| Hypromelloses | HYPROMELLOSE | 3NXW29V3WO | GRANULE / ORAL | 45 mg | ||
| Hypromelloses | HYPROMELLOSE | 3NXW29V3WO | SHAMPOO / TOPICAL | 3 %w/w | ||
| Hypromelloses | HYPROMELLOSE | 3NXW29V3WO | JELLY / TOPICAL | NA | ||
| Hypromelloses | HYPROMELLOSE | 3NXW29V3WO | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 221 mg | ||
| Hypromelloses | HYPROMELLOSE | 3NXW29V3WO | GEL / RECTAL | 348 mg | ||
| Hypromelloses | HYPROMELLOSE | 3NXW29V3WO | TABLET, DELAYED RELEASE / ORAL | 79 mg | ||
| Hypromelloses | HYPROMELLOSE | 3NXW29V3WO | CAPSULE / ORAL | 1488 mg | ||
| Hypromelloses | HYPROMELLOSE | 3NXW29V3WO | CAPSULE, COATED PELLETS / ORAL | 3.32 mg | ||
| Hypromelloses | HYPROMELLOSE | 3NXW29V3WO | SOLUTION / OPHTHALMIC | 0.5 %w/v | ||
| Hypromelloses | HYPROMELLOSE | 3NXW29V3WO | SUSPENSION/ DROPS / OPHTHALMIC | 3 mg | ||
| Hypromelloses | HYPROMELLOSE | 3NXW29V3WO | TABLET, COATED / ORAL | 58 mg | ||
| Hypromelloses | HYPROMELLOSE | 3NXW29V3WO | SYSTEM / TOPICAL | 54 mg | ||
| Hypromelloses | HYPROMELLOSE | 3NXW29V3WO | SYRUP / ORAL | 250 mg | ||
| Hypromelloses | HYPROMELLOSE | 3NXW29V3WO | LOTION / TOPICAL | 0.1 %w/w | ||
| Hypromelloses | HYPROMELLOSE | 3NXW29V3WO | TABLET, CHEWABLE / ORAL | 11.8 mg | ||
| Hypromelloses | HYPROMELLOSE | 3NXW29V3WO | CREAM / TOPICAL | 0.1 %w/w | ||
| Hypromelloses | HYPROMELLOSE | 3NXW29V3WO | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| Hypromelloses | HYPROMELLOSE | 3NXW29V3WO | GRANULE, FOR SUSPENSION / ORAL | 1.7 mg | ||
| Hypromelloses | HYPROMELLOSE | 3NXW29V3WO | SUSPENSION / ORAL | 305 mg | ||
| Hypromelloses | HYPROMELLOSE | 3NXW29V3WO | CAPSULE, EXTENDED RELEASE / ORAL | 119.7 mg | ||
| Hypromelloses | HYPROMELLOSE | 3NXW29V3WO | CAPSULE, DELAYED RELEASE / ORAL | 105 mg | ||
| Hypromelloses | HYPROMELLOSE | 3NXW29V3WO | TABLET / ORAL | 1127 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ddafa3ab-c669-4a06-87be-0d31f16d6ce4 | 313a8be3-37f7-4e4f-aa24-04e031e4bb79 | 2012-12-20 | Warnings | ddafa3ab-c669-4a06-87be-0d31f16d6ce4 313a8be3-37f7-4e4f-aa24-04e031e4bb79 |
Adverse event summaries are temporarily unavailable. Other product information remains available.